702798009: Linagliptin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Peptide hydrolase inhibitor\Dipeptidyl peptidase IV inhibitor\Linagliptin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Linagliptin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Linagliptin (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Linagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Linagliptin (substance)	Is a	Oral hypoglycemic	false	Inferred relationship	Some
Linagliptin (substance)	Is a	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Some
Linagliptin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Some
Linagliptin (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Linagliptin (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Linagliptin (substance)	Is a	Piperidine	true	Inferred relationship	Some
Linagliptin (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Linagliptin (substance)	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Linagliptin (substance)	Inferred relationship	Some
Product containing empagliflozin and linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing linagliptin and metformin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing linagliptin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	2
Linagliptin 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Empagliflozin and linagliptin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing only linagliptin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Linagliptin and metformin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing only linagliptin and metformin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing only linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing only empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely empagliflozin 25 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely linagliptin 2.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	2
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing precisely empagliflozin 10 milligram and linagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Linagliptin (substance)	Inferred relationship	Some	1
Product containing empagliflozin and linagliptin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Linagliptin (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3006132016	Linagliptin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006177019	Linagliptin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49591000195118	linagliptin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820861000172112	linagliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63771000195117	Linagliptin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module